Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Estrogenic activities described for 7alpha-thioestratrienes

Feb. 18, 2000

Purpurinimide photosensitizers with in vivo tumoricidal effects

Feb. 18, 2000

Marine sponges found to produce potent caspase inhibitors

Feb. 17, 2000

Novel vitamin D compounds for cancer, bone disorders

Feb. 17, 2000

MGI Pharma updates irofulven progress during 1999

Feb. 17, 2000

Kyowa Hakko and Geron extend telomerase partnership

Feb. 17, 2000

New gold complexes for X-ray therapy and imaging designed at Meiji Seika

Feb. 16, 2000

MorphoSys achieves milestone in anticancer collaboration with GPC

Feb. 16, 2000

FDA clears small-molecule angiogenesis inhibitor for clinical testing

Feb. 16, 2000

Lymphoma therapeutic from Immunomedics gives positive phase I results

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026